ES2115582T3 - Preparacion y aplicaciones de interferon-gamma. - Google Patents

Preparacion y aplicaciones de interferon-gamma.

Info

Publication number
ES2115582T3
ES2115582T3 ES87306585T ES87306585T ES2115582T3 ES 2115582 T3 ES2115582 T3 ES 2115582T3 ES 87306585 T ES87306585 T ES 87306585T ES 87306585 T ES87306585 T ES 87306585T ES 2115582 T3 ES2115582 T3 ES 2115582T3
Authority
ES
Spain
Prior art keywords
gamma
hulfn
preparation
interferon
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87306585T
Other languages
English (en)
Inventor
Masashi Kurimoio
Masakazu Mitsuhashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP62125777A external-priority patent/JP2632849B2/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of ES2115582T3 publication Critical patent/ES2115582T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE LA PREPARACION Y USOS FARMACEUTICOS DE HULFN-GAMMA DERIVADO DE MIELOMONOCITO HUMANO; PREPARACION DEL ANTICUERPO ANTI-HULFN-GAMMA MNOCLONAL USANDO EL HULFN-GAMMA; Y PURIFICACION DEL HULFN-GAMMA USANDO EL ANTICUERPO MONOCLONAL. EL HULFN-GAMMA ES EFECTIVO EN LA PREVENCION Y TRATAMIENTO DE ENFERMEDADES VIRALES, TUMORES MALIGNOS E INMUNOPATIAS, SOLO O EN COMBINACION CON OTRO LIMFOQUINO Y/O QUIMIOTERAPEUTICO.
ES87306585T 1986-07-25 1987-07-24 Preparacion y aplicaciones de interferon-gamma. Expired - Lifetime ES2115582T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17626686 1986-07-25
JP62125777A JP2632849B2 (ja) 1986-07-25 1987-05-25 γ―インターフェロンの製造方法

Publications (1)

Publication Number Publication Date
ES2115582T3 true ES2115582T3 (es) 1998-07-01

Family

ID=26462104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87306585T Expired - Lifetime ES2115582T3 (es) 1986-07-25 1987-07-24 Preparacion y aplicaciones de interferon-gamma.

Country Status (10)

Country Link
EP (1) EP0254593B1 (es)
AU (1) AU605492B2 (es)
CA (1) CA1340698C (es)
DE (1) DE3752184T2 (es)
DK (1) DK388787A (es)
ES (1) ES2115582T3 (es)
FI (1) FI873237L (es)
FR (1) FR2615737B1 (es)
GB (1) GB2194240B (es)
NO (1) NO173144C (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
US5198212A (en) * 1988-10-31 1993-03-30 University Of Lousville Research Foundation Incorporated Method and compositions for treatment of trauma-associated sepsis with gamma interferon
US6312680B1 (en) * 1990-06-29 2001-11-06 Timothy R. Mosmann Methods of treatment using cytokine synthesis inhibitory factor
JP3467515B2 (ja) * 1994-11-01 2003-11-17 財団法人ルイ・パストゥール医学研究センター インターフェロン活性の測定法
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4460685A (en) * 1980-05-29 1984-07-17 New York University Method of enhancing the production of human γ Interferon
FI820200A7 (fi) * 1981-01-28 1982-07-29 Ges Fyr Biotechnologische Menetelmä vasta-ainetta tuottavien hybridisolujen ja vasta- aineiden valmistamiseksi, hybridisoluja ja vavasta-aineita.
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
GR851626B (es) * 1984-07-05 1985-11-26 Genentech Inc
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody

Also Published As

Publication number Publication date
FR2615737B1 (fr) 1990-08-24
EP0254593A3 (en) 1989-09-27
NO873120D0 (no) 1987-07-24
GB2194240A (en) 1988-03-02
FI873237A7 (fi) 1988-01-26
DK388787A (da) 1988-01-26
EP0254593B1 (en) 1998-04-29
GB8717610D0 (en) 1987-09-03
CA1340698C (en) 1999-08-10
DE3752184D1 (de) 1998-06-04
EP0254593A2 (en) 1988-01-27
AU7610587A (en) 1988-01-28
GB2194240B (en) 1990-09-19
DK388787D0 (da) 1987-07-24
NO873120L (no) 1988-01-26
FI873237L (fi) 1988-01-26
FI873237A0 (fi) 1987-07-23
AU605492B2 (en) 1991-01-17
NO173144C (no) 1993-11-03
DE3752184T2 (de) 1998-10-29
FR2615737A1 (fr) 1988-12-02
NO173144B (no) 1993-07-26

Similar Documents

Publication Publication Date Title
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
DE68912155D1 (de) Antivirales Kombinationspräparat.
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
EP0163582A3 (en) Medicines which improve the free-flowing properties of blood, and their therapeutical use
IT8419681A0 (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ES2061496T3 (es) Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE68908119D1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
MY111746A (en) Therapeutic nucleosides.
NO900121L (no) Probursin.
IT1224673B (it) Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
RO95622A2 (ro) Produs medicamentos destinat tratamentului ulcerului gastric
RO92916A2 (ro) Medicament biostimulator destinat tratamentului insuficientelor medulare si hepatitelor virale
NO863976D0 (no) Cystein-beroevede muteiner av biologisk aktive human tumornekrosefaktorproteiner.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254593

Country of ref document: ES